According to GlobalData’s medical device pipeline database, 29 Tissue Adhesives devices are in various stages of development globally. GlobalData’s report Tissue Adhesives provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 19 are in active development, while the remaining ten are in an inactive stage of development. There are 16 products in the early stages of development, and the remaining three are in the late stages of development.
Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. This allows for proper healing of the wound under the film and protects the wound from microbial infections. Tissue adhesives based on their composition can be classified as cyanoacrylate-based tissue adhesives and other cross-linkable polymer based tissue adhesives. The volume of tissue adhesive used per procedure varies depending on the type of procedure and formulation. Thus, one unit of tissue adhesive is defined as the average volume used for a single procedure.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Tissue Adhesives pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Tissue Adhesives devices. Overall, most of these Tissue Adhesives pipeline devices are being developed by private entities.
Key players involved in the active development of Tissue Adhesives include Tissium, OptMed, Massachusetts Institute of Technology, Aleo BME, Northwestern University, University of Galway, University of Kansas, Alumend, Artivion and BioDevek.
For a complete picture of the developmental pipeline for Tissue Adhesives devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.